![]() |
市场调查报告书
商品编码
1625015
全球睡眠呼吸中止设备市场规模(按诊断设备、治疗设备、地区、范围和预测)Global Sleep Apnea Devices Market Size By Diagnostic Devices, By Therapeutic Devices, By Geographic Scope And Forecast |
睡眠呼吸中止症设备的全球市场推动因素
睡眠呼吸中止症设备市场的市场推动因素可能受到多种因素的影响。
睡眠呼吸中止症盛行率不断上升
一个重要因素是全球睡眠呼吸中止症的盛行率不断上升。久坐的生活方式、肥胖、人口老化以及认识和诊断的提高等多种因素促使寻求治疗的患者数量增加。
技术开发
技术进步使得更舒适、更有效、更容易使用的睡眠呼吸中止症治疗设备得以开发。持续性呼吸道正压通气 (CPAP) 设备、口腔器具和其他设备的设计、功能和连接性的改进正在改善治疗效果和患者的依从性。
提高知名度和认可度
公众和医疗保健专业人员对未治疗的睡眠呼吸中止症相关的健康风险的认识不断提高,促使诊断率上升。随着越来越多的人被诊断出患有睡眠呼吸暂停,对有效治疗工具的需求也随之增加。
增加医疗支出
先进睡眠呼吸中止症设备的使用受到医疗保健支出的增加的推动,尤其是在已开发国家。市场成长也将受到睡眠呼吸中止症治疗的保险覆盖范围和报销指南的影响。
家庭医疗保健的趋势:
在家中管理睡眠呼吸中止症等慢性疾病的趋势推动了对便携式、易于使用的设备的需求。患者更喜欢微创治疗,因为这样他们就可以控制疾病而不干扰他们的日常生活。
伙伴关係与合作关係
尖端睡眠呼吸中止症设备的开发由主要行业参与者、医疗保健提供者和研究机构之间的合作推动。这些合作透过促进资讯、资源和技术的共享促进了市场扩张。
政府计画
睡眠呼吸中止症市场可能会受益于政府针对睡眠障碍的计划、支持宣传活动以及增强医疗服务的机会。价格低廉的设备研发和销售将得到政策的支持,这也将有助于市场的扩大。
老年人口增加
肥胖和肌肉力量下降使老年人更容易患睡眠呼吸中止症。随着老年人口的增加,对诊断和治疗睡眠呼吸中止症的工具的需求预计会增加。
限制全球睡眠呼吸中止设备市场的因素
有几个因素可能会对睡眠呼吸中止症设备市场造成限製或课题。
成本高
许多睡眠呼吸中止症治疗的费用可能促使无法获得治疗,特别是对于医疗保健较差或缺乏足够保险的地区的人们。
有限补偿政策
在某些地区,当保险无法完全承担睡眠呼吸中止症设备的费用时,患者可能会面临经济障碍。
认知度低
患者和医疗保健专业人员通常缺乏有关睡眠呼吸中止问题及其可用治疗方法的瞭解,这可能促使误诊和治疗不足。
副作用
有些患者在使用睡眠呼吸中止症设备时可能会感到不适或副作用。这些症状包括面罩过敏和难以适应持续性呼吸道正压通气 (CPAP) 治疗。
合规性问题
由于各种原因,包括不适、不便以及难以适应在睡觉时佩戴设备,一些患者可能难以坚持他们的治疗计划,尤其是 CPAP 治疗。
替代疗法
儘管外科手术和口腔器具可能会与睡眠呼吸中止症设备市场竞争,但有些人可能更喜欢或选择这些替代方法来治疗睡眠呼吸中止症。
监理障碍
严格的医疗器材监管法律可能会延长睡眠呼吸中止症治疗的开发和商业化所需的时间,并可能阻碍创新和市场发展。
限制获得医疗保健的机会
在缺乏专业睡眠诊所和医疗保健服务的地区,患者可能难以及时得到睡眠呼吸中止症的诊断和治疗。
Sleep Apnea Devices Market size was valued at USD 5.8 billion in 2023 and is projected to reach USD 8.0 billion by 2030 , growing at a CAGR of 6.5% during the forecast period 2024-2030. Global Sleep Apnea Devices Market Drivers The market drivers for the Sleep Apnea Devices Market can be influenced by various factors. These may include:
Growing Prevalence of Sleep Apnea
One important contributing factor is the increasing incidence of sleep apnea worldwide. The number of patients seeking therapy is rising due to a number of factors including sedentary lifestyles, obesity, aging populations, and improved awareness and diagnosis.
Technological Developments
The creation of more cozy, effective, and user-friendly sleep apnea equipment is the result of technological advancements. The design, functionality, and connection of continuous positive airway pressure (CPAP) machines, oral appliances, and other devices have improved, improving treatment outcomes and patient compliance.
Increasing Recognition and Recognition Rates
Higher rates of diagnosis have resulted from increased knowledge of the health dangers associated with untreated sleep apnea among both the general public and healthcare professionals. There is an increasing need for efficient treatment tools as more people receive sleep apnea diagnoses.
Growing Healthcare Expenditure
The use of sophisticated sleep apnea equipment is encouraged by rising healthcare spending, especially in industrialized nations. The market's growth is also influenced by insurance coverage and reimbursement guidelines for sleep apnea treatments.
Trend toward Home-based Care:
The need for portable, user-friendly equipment is being driven by the trend toward managing chronic illnesses, such as sleep apnea, at home. Patients like minimally invasive therapies that enable them to control their illness without interfering with their regular routines.
Partnerships and Collaborations
The creation of cutting-edge sleep apnea equipment is facilitated by partnerships and collaborations amongst major industry participants, healthcare providers, and research institutes. These collaborations promote market expansion by facilitating the sharing of information, resources, and technology.
Government programs
The market for sleep apnea devices may benefit from government programs that target sleep disorders, support awareness campaigns, and enhance access to healthcare services. The development and marketing of inexpensive devices are aided by policies, which also contribute to market expansion.
Growing Senior Population
Obesity and a loss of muscle tone make the elderly population more prone to sleep apnea. The need for tools to diagnose and treat sleep apnea is predicted to increase as the number of elderly people increases..
Global Sleep Apnea Devices Market Restraints
Several factors can act as restraints or challenges for the Sleep Apnea Devices Market. These may include:
Expensive Cost
A lot of sleep apnea devices can be pricey, which may prevent patients from getting them, particularly in areas with little access to healthcare or for those without sufficient insurance.
Limited Reimbursement Policies
Patients seeking treatment may face financial obstacles if their insurance does not sufficiently cover the cost of sleep apnea devices in specific areas.
Low Awareness
Patients and medical professionals may misdiagnose or undertreat sleep apnea as a result of a lack of knowledge regarding the problem and the available treatments.
Adverse Effects
When utilizing some sleep apnea devices, some patients may have discomfort or side effects. These include irritability from masks or trouble adjusting to continuous positive airway pressure (CPAP) therapy.
Problems with Compliance
Some patients may find it difficult to adhere to treatment plans, especially when it comes to CPAP therapy, for a variety of reasons, including discomfort, inconvenience, or trouble getting used to wearing the device while they sleep.
Alternative Therapies
While surgical procedures and oral appliances can compete with the market for sleep apnea devices, some individuals may prefer or choose these alternative approaches to treating their sleep apnea.
Regulatory Obstacles
Tight laws governing medical devices could lengthen the time it takes to develop and commercialize sleep apnea solutions, thereby impeding innovation and market expansion.
Restricted Access to Healthcare
Patients may encounter difficulties receiving a prompt diagnosis and treatment for sleep apnea in areas with limited access to specialized sleep clinics or healthcare services, which may affect the market demand for sleep apnea devices..
The Global Sleep Apnea Devices Market is Segmented on the basis of By Diagnostic Devices, By Therapeutic Devices, and Geography.
Polysomnography (PSG) devices
Devices that use polysomnography (PSG) are the gold standard for identifying sleep apnea. PSG tests entail spending the night in a sleep lab under continuous physiological monitoring.
Devices for home sleep testing (HST):
An easier and more affordable way to diagnose sleep apnea is with a HST device. They are usually used at home and are designed to monitor specific physiological functions..
Positive Airway Pressure (PAP) devices
The most often used kind of treatment for sleep apnea is the use of PAP devices. They function by maintaining the airway open while you sleep by applying pressured air. Continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP), and auto-titrating positive airway pressure (APAP) are the three primary categories of PAP devices.
Oral Appliances
To help maintain the airway open while you sleep, oral appliances are a sort of mouthpiece. Although they are usually not as effective as PAP devices, they could be a suitable substitute for those who are unable to undergo PAP therapy.
Implantable Devices
Currently in development, implantable devices represent a novel approach to treating sleep apnea. The way these gadgets function is by stimulating the nerves that govern the tongue and throat muscles.
North America:
Market conditions and demand in the United States, Canada, and Mexico.
Europe:
Analysis of the Sleep Apnea Devices Market in European countries.
Asia-Pacific:
Focusing on countries like China, India, Japan, South Korea, and others.
Middle East and Africa:
Examining market dynamics in the Middle East and African regions.
Latin America:
Covering market trends and developments in countries across Latin America.
The major players in the Sleep Apnea Devices Market are:
ResMed Inc.
Philips Respironics (a division of Royal Philips)
Fisher & Paykel Healthcare
SomnoMed
BMC Medical Co.Ltd.
Drive DeVilbiss Healthcare
Braebon Medical Corporation
Compumedics Limited
Whole You Inc. (a subsidiary of Mitsui Chemicals.Inc.)
Fisher Wallace